[Prognosis in olfaction disorders].
Hirakawa
Katsuhiro
K
D000281:Administration, Intranasal; D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006259:Craniocerebral Trauma / Q000150:complications; D019937:Diagnostic Techniques and Procedures; D006801:Humans; D000857:Olfaction Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000523:psychology; D011237:Predictive Value of Tests; D011379:Prognosis; D012684:Sensory Thresholds; D012852:Sinusitis / Q000150:complications; D012903:Smell; D013831:Thiamine / Q000031:analogs & derivatives*; D013997:Time Factors; D014222:Triamcinolone Acetonide / Q000008:administration & dosage
C028994:betamethasone sodium phosphate; D001623:Betamethasone; D014222:Triamcinolone Acetonide; C013294:prosultiamine; D013831:Thiamine